Sol-Gel Technologies

General Information

We are a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Our current product candidate pipeline consists of late-stage branded product candidates that leverage our proprietary, silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.

Employees: 47
Founded: 1997
Contact Information
Address 7 Golda Meir St., Weizmann Science Park, Ness Ziona, 7403650, Israel
Phone Number +972-8-931-3433
Web Address
View Prospectus: Sol-Gel Technologies
Financial Information
Market Cap $215.8mil
Revenues $0 mil (last 12 months)
Net Income $-31.0 mil (last 12 months)
IPO Profile
Symbol SLGL
Exchange NASDAQ
Shares (millions): 6.3
Price range $12.00 - $12.00
Est. $ Volume $75.0 mil
Manager / Joint Managers ​Jefferies/ BMO Capital Markets​
CO-Managers JMP Securities/ Raymond James​
Expected To Trade: 2/1/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change